Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Long-term Effects of Acoltremon vs. Control in Dry Eye DiseaseRecruiting
NCT07659626N/AUpdated Aug 20, 2026
Sponsor: The Eye Care Institute
Dry Eye
United States
UK SMA Patient RegistryRecruiting
NCT04292574N/AUpdated Aug 20, 2026
Sponsor: Newcastle University
Spinal Muscular Atrophy · SMA
United Kingdom
Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaRecruiting
NCT07170917Phase 2Updated Aug 20, 2026
Sponsor: Sanofi
Hidradenitis Suppurativa
United States, Australia, Canada, Chile, China +14 more
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell CarcinomaRecruiting
NCT07123090Phase 2Updated Aug 20, 2026
Sponsor: Stephanie Berg
Metastatic Renal Cell Carcinoma · Metastatic Renal Cancer · Renal Cell Carcinoma · Advanced Clear Cell Renal Cell Carcinoma
United States
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood PressureRecruiting
NCT05903950NAUpdated Aug 20, 2026
Sponsor: Weill Cornell Medical College in Qatar
Hypertension, Systolic · Metabolic Syndrome
Qatar
Phase II Clinical Trial of SHR-1139 Injection in Patients With PsoriasisRecruiting
NCT07719530Phase 2Updated Aug 20, 2026
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Psoriasis
China
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple MyelomaRecruiting
NCT04910568Phase 1Updated Aug 20, 2026
Sponsor: Genentech, Inc.
Multiple Myeloma
United States, Australia, Canada, Czechia, Denmark +8 more
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaRecruiting
NCT07129993Phase 2, Phase 3Updated Aug 20, 2026
Sponsor: Daiichi Sankyo
Urothelial Cancer · Bladder Cancer
United States, Austria, China, France, Germany +2 more
Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK TrialRecruiting
NCT07141355NAUpdated Aug 20, 2026
Sponsor: University Hospital, Strasbourg, France
Cardiogenic Shock
France
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy ParticipantsRecruiting
NCT06577337Phase 1Updated Aug 20, 2026
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Healthy
Germany
Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver TransplantationRecruiting
NCT07335523N/AUpdated Aug 20, 2026
Sponsor: Digestive Care, Inc.
Exocrine Pancreatic Insuficiency
United States
Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid CancerRecruiting
NCT07777536Phase 2Updated Aug 20, 2026
Sponsor: Fudan University
Thyroid Cancer
China
Alveolar Ridge Preservation (ARP) in the Posterior Maxilla After the Extraction of Maxillary MolarsRecruiting
NCT07433322NAUpdated Aug 20, 2026
Sponsor: Virginia Commonwealth University
Alveolar Bone Loss
United States
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized TrialRecruiting
NCT07227077NAUpdated Aug 20, 2026
Sponsor: Medical College of Wisconsin
Breast Cancer · Cervical Cancer · Bladder Cancer · Colorectal Cancer
United States
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicityRecruiting
NCT07077239N/AUpdated Aug 20, 2026
Sponsor: Jonsson Comprehensive Cancer Center
Prostate Cancer (CRPC)
United States
A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New YorkRecruiting
NCT06681077NAUpdated Aug 20, 2026
Sponsor: Roswell Park Cancer Institute
Healthy
United States
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaRecruiting
NCT07012044Phase 1Updated Aug 20, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia Post Cytotoxic Therapy · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
United States
Shift Workers' Health Behavior Action Program Across EuropeRecruiting
NCT07631767NAUpdated Aug 20, 2026
Sponsor: Wageningen University
Night Shift Work · Obesity & Overweight · Circadian Misalignment
Germany, Netherlands, Poland
Pivotal Study of N-acetyl-L-leucine for CACNA1ARecruiting
NCT07221292Phase 3Updated Aug 20, 2026
Sponsor: IntraBio Inc
CACNA1A · Spinocerebellar Ataxia Type 6 · Episodic Ataxia Type 2 · Familial Hemiplegic Migraine-1
United States, Austria, Germany, Greece, Italy +2 more
Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisRecruiting
NCT07332091Phase 2Updated Aug 20, 2026
Sponsor: CSL Behring
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis
United States, Australia, Austria, Belgium, Canada +13 more
Clinical and Genetic Studies in Familial Non-medullary Thyroid CancerRecruiting
NCT01109420N/AUpdated Aug 20, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Non-Medullary Thyroid Cancer
United States
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy ParticipantsRecruiting
NCT07723833Phase 1Updated Aug 20, 2026
Sponsor: AstraZeneca
Healthy Participants
United States
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT06819878Phase 3Updated Aug 20, 2026
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Argentina, Australia, Austria, Belgium +33 more
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusRecruiting
NCT07340320Phase 2Updated Aug 20, 2026
Sponsor: Corxel Pharmaceuticals
Type II Diabetes Mellitus
United States, Poland
Intestinal Ultrasound Guided Management in Inflammatory Bowel DiseaseRecruiting
NCT07775352NAUpdated Aug 20, 2026
Sponsor: Mahidol University
Inflammatory Bowel Diseases · Crohn Disease · Colitis, Ulcerative
Thailand

Previous page Next page